申请人:Abbott Laboratories
公开号:US05616596A1
公开(公告)日:1997-04-01
The invention relates to compounds having activity to inhibit lipoxygenase enzyme activity, to pharmaceutical compositions comprising these compounds, and to a medical method of treating. More particularly, this invention concerns certain substituted arylalkynyl- and ((heteroaryl)alkynyl)-N-hydroxy-ureas which inhibit leukotriene biosynthesis, to pharmaceutical compositions of these compounds and to a method of inhibiting leukotriene biosynthesis.
该发明涉及具有抑制脂氧酶酶活性的化合物,包括这些化合物的药物组合物,以及治疗的医学方法。更具体地说,这项发明涉及特定的取代芳基炔基和((杂环)炔基)-N-羟基脲,这些化合物抑制白三烯生物合成,以及这些化合物的药物组合物和抑制白三烯生物合成的方法。